INTERNATIONAL PATENT: ENLIVEN INC. FILES APPLICATION FOR "5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES FOR USE IN THE TREATMENT OF CANCER"

GENEVA, April 29 -- ENLIVEN INC. (6200 Lookout Road, Floor 1Boulder, Colorado 80301-3319) filed a patent application (PCT/US2025/050290) for "5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES FOR USE IN THE TREATMENT OF CANCER" on Oct 09, 2025. With publication no. WO/2026/084950, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GROSS, Stefan (c/o Enliven Inc.6200 Lookout Road, Floor 1Boulder, Colorado 80301-3319), COLLINS, Helen (c/o Enliven Inc.6200 Lookout Road, Floor 1Boulder, Colorado 80301-3319)...